Unicycive Therapeutics to Participate in a Fireside Chat at the Guggenheim 2nd Annual Healthcare Innovation Conference

Unicycive Therapeutics to Participate in a Fireside Chat at the Guggenheim 2nd Annual Healthcare Innovation Conference GlobeNewswire November 03, 2025 LOS ALTOS, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) — Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company” or “Unicycive”), today announced that Shalabh Gupta, M.D., […]

Vertex Announces Third Quarter 2025 Financial Results and $150 Million Class A Common Stock Repurchase Program

Vertex Announces Third Quarter 2025 Financial Results and $150 Million Class A Common Stock Repurchase Program GlobeNewswire November 03, 2025 KING OF PRUSSIA, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) — Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a leading global provider of indirect tax solutions, today announced financial results for its third quarter ended

Scam Encounters Every Four Days: Mexico’s Financial Toll

This study of 1,000 Mexican adults reveals that over three-quarters have encountered a scam, with an average of one scam encounter happening every four days, equating to 86 scam encounters on average per person per year in Mexico. THE HAGUE, NL / ACCESS Newswire / November 3, 2025 / Additionally, nearly 3/5 of Mexican adults

New Report Reveals Disconnect Between Short-Term Focus and Long-Term, Data-Backed Growth Strategies for Health Systems

New Report Reveals Disconnect Between Short-Term Focus and Long-Term, Data-Backed Growth Strategies for Health Systems National survey of healthcare leaders suggests investing in AI, preventive care, and specialist integration could strengthen financial sustainability GlobeNewswire November 03, 2025 BOSTON, Nov. 03, 2025 (GLOBE NEWSWIRE) — Arcadia(R) (arcadia.io), a leading healthcare data platform, today announced the publication

MRX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Marex Group plc Investors Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESS Newswire / November 3, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Marex Group plc ("Marex" or "the Company") (NASDAQ:MRX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against

Mason Law Provides Corporate Update

Mason Law Provides Corporate Update GlobeNewswire November 03, 2025 TORONTO, Nov. 03, 2025 (GLOBE NEWSWIRE) — Mason Law is pleased to announce that its Founder and President, Robert Mason, has been recognized by The Best Lawyers in Canada(TM) for his exceptional work in Mining Law and has also been included in the Lexpert Special Edition:

MacroMT Unveils Corporate Vision Blueprint, Defining Mission and Core Values for the New Era of Fintech

MacroMT Unveils Corporate Vision Blueprint, Defining Mission and Core Values for the New Era of Fintech GlobeNewswire November 03, 2025 DENVER, Colorado, Nov. 03, 2025 (GLOBE NEWSWIRE) — Macro Technology Group (“MacroMT”), a global leader in multi-asset trading and quantitative intelligence, today released its new Corporate Vision Blueprint outlining the company's strategic mission and core

CPTN Investors Have Opportunity to Lead Cepton, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!

NEW YORK CITY, NY / ACCESS Newswire / November 3, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Cepton, Inc. ("Cepton" or "the Company") (NASDAQ:CPTN) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants

J-Star Receives USAPA Approval for its Second In-House Pickleball Paddle, Supernova

J-Star Receives USAPA Approval for its Second In-House Pickleball Paddle, Supernova GlobeNewswire November 03, 2025 TAICHUNG CITY, Taiwan, Nov. 03, 2025 (GLOBE NEWSWIRE) — J-Star Holding Co., Ltd. (Nasdaq: YMAT) (“J-Star” or the “Company”), a leading provider of innovative carbon fiber and composite solutions across a wide range of applications including personal sports equipment, healthcare

FDA Approves Anteris’s DurAVR(R) THV Global Pivotal Trial (the “PARADIGM Trial”)

FDA Approves Anteris's DurAVR(R) THV Global Pivotal Trial (the “PARADIGM Trial”) GlobeNewswire November 03, 2025 PARADIGM: A Prospective rAndomized tRial Assessing the safety and effectiveness of the DurAVR(R) bIomimetic valve designed for physioloGic flow compared to CoMmercial TAVR devices MINNEAPOLIS and BRISBANE, Australia, Nov. 03, 2025 (GLOBE NEWSWIRE) — Anteris announced today it has received

Scroll to Top